Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Escherichia coli | peptide deformylase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0061 | 0 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0279 | 0.7552 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0143 | 0.286 | 0.3787 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Entamoeba histolytica | Rad52/22 family double-strand break repair protein, putative | 0.0099 | 0.1331 | 0.016 |
Giardia lamblia | DNA repair protein RAD52 | 0.0349 | 1 | 1 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0266 | 0.7092 | 0.9392 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0143 | 0.286 | 0.3787 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.7809 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0061 | 0 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.7809 |
Chlamydia trachomatis | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.1573 | 0.5 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0279 | 0.7552 | 1 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Plasmodium vivax | peptide deformylase, putative | 0.0279 | 0.7552 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0099 | 0.1331 | 0.016 |
Mycobacterium ulcerans | peptide deformylase | 0.0279 | 0.7552 | 1 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0106 | 0.1573 | 0.5 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0294 | 0.807 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.119 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0061 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0279 | 0.7552 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0106 | 0.1573 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0106 | 0.1573 | 0.5 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0294 | 0.807 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0279 | 0.7552 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.098 uM | Inhibition of the isolated native E. coli peptide deformylase (PDF) | ChEMBL. | 11384231 |
IC50 (binding) | = 0.098 uM | Inhibition of the isolated native E. coli peptide deformylase (PDF) | ChEMBL. | 11384231 |
MIC (functional) | = 4 ug ml-1 | In vitro antibacterial activity against Moraxella catarrhalis RA21 | ChEMBL. | 11384231 |
MIC (functional) | = 32 ug ml-1 | In vitro antibacterial activity against Escherichia coli | ChEMBL. | 11384231 |
MIC (functional) | = 32 ug ml-1 | In vitro antibacterial activity against Escherichia coli | ChEMBL. | 11384231 |
MIC (functional) | > 64 ug ml-1 | In vitro antibacterial activity against Haemophilus influenzae 11 | ChEMBL. | 11384231 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.